Results 21 to 30 of about 3,016,518 (294)

Antihypertensive therapy in obesity

open access: yesМедицинский совет, 2014
Obesity today is one of the most relevant interdisciplinary problems in healthcare and one of the key reasons for blood pressure increase. Thus, according to the Framingham Heart Study,78% of hypertension in men and 65% in women can be directly ...
S. V. Nedogoda   +5 more
doaj   +1 more source

СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION

open access: yesРациональная фармакотерапия в кардиологии, 2016
Problems of antihypertensive therapy are discussed in the light of the present epidemiological situation with arterial hypertension. ACE inhibitors have a special place among the antihypertensive drugs.
N. A. Dzhaiani
doaj   +1 more source

Medication taking behaviour and hypertension: A review of the literature [PDF]

open access: yes, 2009
Hypertension is a global illness and one that affects circa 20% of the population. Despite the effectiveness of treatment, adherence with medication is a key concern, particularly in the elderly.
Banning, M
core   +4 more sources

Up-to-Date Approach to the Treatment of Hypertension

open access: yesHaseki Tıp Bülteni, 2014
Hypertension remains one of the most important medical problems in spite of significant medical advances. In many studies, both systolic and diastolic blood pressures have been found to be closely related with cardiovascular (CV) morbidity and mortality.
Zeki Aydın, Savaş Öztürk
doaj   +1 more source

Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?

open access: yesCardiology Research and Practice, 2020
Risk factors for cardiovascular disease such as hypertension and hyperlipidemia are associated with cognitive decline. However, there is still no clear evidence that the use of antihypertensive or lipid-lowering therapy can prevent or delay cognitive ...
Ze-Min Kuang
doaj   +1 more source

Pharmacoeconomic analysis of physiotens in patientswith arterial hypertension, overweight and type 2 diabetes mellitusin framework of Russian Public Health System

open access: yesОжирение и метаболизм, 2009
The present article represent a pharmacoeconomic comparison of standard antihypertensive therapy and the same therapy plus moxonidine (Physiotens) in patients with arterial hypertension, overweight and diabetes mellitus type 2. The budget impact analysis

doaj   +1 more source

THE APPLICATION OF COMBINED PREPARATIONS WITH CONSTANT DOSES OF ANTIHYPERTENSIVE DRUGS AS THE INITIAL TACTICS OF TREATMENT AT HIGH BLOOD PRESSURE LEVEL: PROVEN FACTS AND EXPERT’S OPINION

open access: yesЕвразийский Кардиологический Журнал, 2021
In this article the current problems of the use of combined antihypertensive drugs in the implementation of «tactics one tablet» in a wide range of patients with arterial hypertension are discussed.
S. R. Gilyarevskij   +4 more
doaj   +1 more source

ОСОБЕННОСТИ ЛЕЧЕНИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ У МУЖЧИН С ОПУХОЛЬЮ ПОЧКИ ПОСЛЕ ЛАПАРОСКОПИЧЕСКОЙ НЕФРЭКТОМИИ

open access: yesАрхивъ внутренней медицины, 2014
Objective of the study is to analyze the dynamics of blood pressure in the early postoperative period in patients with a tumor of the kidney and hypertension after laparoscopic nephrectomy.
С. С. Давыдова
doaj   +1 more source

Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men

open access: yesThe Journal of Clinical Hypertension, 2021
Testosterone replacement therapies have been shown to increase blood pressure (BP) in hypogonadal men. We studied the effects of a new formulation of testosterone undecanoate (Kyzatrex™) on ambulatory blood pressure (ABP) and heart rate, in 155 men with ...
William B. White   +3 more
doaj   +1 more source

Hypertension in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma in ALPINE: a secondary analysis

open access: yesBlood Neoplasia
: Hypertension is a common side effect of Bruton tyrosine kinase inhibitors (BTKis). The second-generation BTKi zanubrutinib has high BTK selectivity, which may minimize off-target effects.
June-Wha Rhee   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy